Octagon Capital Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-904,000	Closed	-$11.1M	–	33
2025 Q1	$11.1M	Hold	904,000	–	–	2.15%	19
2024 Q4	$12M	Buy	+904,000	New	+$12M	1.97%	21